APOE and Alzheimer disease: However, their associations with late-life cognitive disorders are relatively weak, although a polygenic risk score outside the APOE ε4 locus may help improve risk prediction for MCI and Alzheimer’s disease (Chouraki et al., 2016; Logue et al., 2019).